These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15041730)

  • 1. Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase isozyme 3 in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.
    Miyahara N; Shoda J; Kawamoto T; Furukawa M; Ueda T; Todoroki T; Tanaka N; Matsuo K; Yamada Y; Kohno K; Irimura T
    Clin Cancer Res; 2004 Mar; 10(6):2090-9. PubMed ID: 15041730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
    Kawamoto T; Shoda J; Irimura T; Miyahara N; Furukawa M; Ueda T; Asano T; Kano M; Koike N; Fukao K; Tanaka N; Todoroki T
    Clin Cancer Res; 2001 May; 7(5):1333-42. PubMed ID: 11350903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cyclooxygenase-2 in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
    Kawamoto T; Shoda J; Asano T; Ueda T; Furukawa M; Koike N; Tanaka N; Todoroki T; Miwa M
    Int J Cancer; 2002 Mar; 98(3):427-34. PubMed ID: 11920595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-3 (GalNAc-T3) expression in patients with gastric carcinoma.
    Onitsuka K; Shibao K; Nakayama Y; Minagawa N; Hirata K; Izumi H; Matsuo K; Nagata N; Kitazato K; Kohno K; Itoh H
    Cancer Sci; 2003 Jan; 94(1):32-6. PubMed ID: 12708471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MUC1 recognized by a monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of carcinoma of the gallbladder.
    Kawamoto T; Shoda J; Miyahara N; Suzuki H; Furukawa M; Todoroki T; Tanaka N; Irimura T
    Clin Exp Metastasis; 2004; 21(4):353-62. PubMed ID: 15554392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.
    Onuki K; Sugiyama H; Ishige K; Kawamoto T; Ota T; Ariizumi S; Yamato M; Kadota S; Takeuchi K; Ishikawa A; Onodera M; Onizawa K; Yamamoto M; Miyoshi E; Shoda J
    J Gastroenterol; 2014 Apr; 49(4):702-14. PubMed ID: 23588887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression pattern of UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetyl-galactosaminyl transferase-3 in squamous cell carcinoma of the esophagus.
    Ishikawa M; Kitayama J; Kohno K; Nagawa H
    Pathobiology; 2005; 72(3):139-45. PubMed ID: 15860931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of GalNAc-T3 and its relationships with clinicopathological factors in 61 extrahepatic bile duct carcinomas analyzed using stepwise sections - special reference to its association with lymph node metastases-.
    Inoue T; Eguchi T; Oda Y; Nishiyama K; Fujii K; Izumi H; Kohno K; Yamaguchi K; Tanaka M; Tsuneyoshi M
    Mod Pathol; 2007 Feb; 20(2):267-76. PubMed ID: 17361208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong expression of polypeptide N-acetylgalactosaminyltransferase 3 independently predicts shortened disease-free survival in patients with early stage oral squamous cell carcinoma.
    Harada Y; Izumi H; Noguchi H; Kuma A; Kawatsu Y; Kimura T; Kitada S; Uramoto H; Wang KY; Sasaguri Y; Hijioka H; Miyawaki A; Oya R; Nakayama T; Kohno K; Yamada S
    Tumour Biol; 2016 Jan; 37(1):1357-68. PubMed ID: 26296622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression pattern of UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 in early gastric carcinoma.
    Ishikawa M; Kitayama J; Nariko H; Kohno K; Nagawa H
    J Surg Oncol; 2004 Apr; 86(1):28-33. PubMed ID: 15048677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma.
    Shibao K; Izumi H; Nakayama Y; Ohta R; Nagata N; Nomoto M; Matsuo K; Yamada Y; Kitazato K; Itoh H; Kohno K
    Cancer; 2002 Apr; 94(7):1939-46. PubMed ID: 11932895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular localization of MUC1 recognized by a monoclonal antibody MY.1E12 correlates with postsurgical prognosis in differentiated-type gastric carcinomas of stage II and III.
    Shinozaki E; Adachi S; Shoda J; Kawamoto T; Suzuki H; Irimura T; Ohkohchi N
    Int J Oncol; 2004 Nov; 25(5):1257-65. PubMed ID: 15492813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat.
    Bennett EP; Hassan H; Mandel U; Mirgorodskaya E; Roepstorff P; Burchell J; Taylor-Papadimitriou J; Hollingsworth MA; Merkx G; van Kessel AG; Eiberg H; Steffensen R; Clausen H
    J Biol Chem; 1998 Nov; 273(46):30472-81. PubMed ID: 9804815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of three UDP-N-acetyl-alpha-D-galactosamine:polypeptide GalNAc N-acetylgalactosaminyltransferases in adenocarcinoma cell lines.
    Sutherlin ME; Nishimori I; Caffrey T; Bennett EP; Hassan H; Mandel U; Mack D; Iwamura T; Clausen H; Hollingsworth MA
    Cancer Res; 1997 Nov; 57(21):4744-8. PubMed ID: 9354435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of uridine diphosphate N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas.
    Yamamoto S; Nakamori S; Tsujie M; Takahashi Y; Nagano H; Dono K; Umeshita K; Sakon M; Tomita Y; Hoshida Y; Aozasa K; Kohno K; Monden M
    Pathobiology; 2004; 71(1):12-8. PubMed ID: 14555840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy.
    Bennett EP; Hassan H; Mandel U; Hollingsworth MA; Akisawa N; Ikematsu Y; Merkx G; van Kessel AG; Olofsson S; Clausen H
    J Biol Chem; 1999 Sep; 274(36):25362-70. PubMed ID: 10464263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth.
    Taniuchi K; Cerny RL; Tanouchi A; Kohno K; Kotani N; Honke K; Saibara T; Hollingsworth MA
    Oncogene; 2011 Dec; 30(49):4843-54. PubMed ID: 21625220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of the sugar recognition ability of the lectin domain of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 by using unnatural glycopeptide substrates.
    Yoshimura Y; Nudelman AS; Levery SB; Wandall HH; Bennett EP; Hindsgaul O; Clausen H; Nishimura S
    Glycobiology; 2012 Mar; 22(3):429-38. PubMed ID: 22042768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-D-galactosamine. Polypeptide N-acetylgalactosaminyltransferase, GalNAc-t3.
    Bennett EP; Hassan H; Clausen H
    J Biol Chem; 1996 Jul; 271(29):17006-12. PubMed ID: 8663203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence.
    Gu C; Oyama T; Osaki T; Li J; Takenoyama M; Izumi H; Sugio K; Kohno K; Yasumoto K
    Br J Cancer; 2004 Jan; 90(2):436-42. PubMed ID: 14735190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.